blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1553960

EP1553960 - NEUREGULIN BASED METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.01.2018
Database last updated on 07.10.2024
FormerThe patent has been granted
Status updated on  17.02.2017
FormerGrant of patent is intended
Status updated on  15.12.2016
FormerExamination is in progress
Status updated on  18.11.2016
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Zensun (Shanghai) Science & Technology, Co., Ltd.
No. 68 Ju Li Road
Zhangjiang Hi-Tech Park
Pudong
Shanghai 201203 / CN
[2016/31]
Former [2010/28]For all designated states
Zensun (Shanghai) Science and Technology Limited
No.68 Ju Li Road Zhangjiang Hi-Tech Park
Shanghai 201203 / CN
Former [2005/29]For all designated states
Zensun (Shanghai) Sci-Tech, Ltd.
No. 328 Bibo Road, Hi-Tech Park, Zhangjiang
Shanghai 201203 / CN
Inventor(s)01 / ZHOU, Mingdong
No. 328 Bibo Road
Hi-Tech Park
Zhangjiang, Shanghai 201203 / CN
 [2017/12]
Former [2005/29]01 / ZHOU, Mingdong
No. 328 Bibo Road, Hi-Tech Park
Zhangjiang, Shanghai 201203 / CN
Representative(s)Weber, Martin, et al
Jones Day
Prinzregentenstraße 11
80538 München / DE
[2017/12]
Former [2009/08]Weber, Martin, et al
Jones Day Prinzregentenstrasse 11
80538 München / DE
Former [2005/29]Otten, Hajo, Dr.-Ing., et al
Witte, Weller & Partner Patentanwälte, Postfach 105462
70047 Stuttgart / DE
Application number, filing date03732172.615.05.2003
[2005/29]
WO2003CN00355
Priority number, dateWO2002CN0034924.05.2002         Original published format: PCT/CN02/00349
[2005/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03099300
Date:04.12.2003
Language:EN
[2003/49]
Type: A1 Application with search report 
No.:EP1553960
Date:20.07.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 04.12.2003 takes the place of the publication of the European patent application.
[2005/29]
Type: B1 Patent specification 
No.:EP1553960
Date:22.03.2017
Language:EN
[2017/12]
Search report(s)International search report - published on:CN04.12.2003
(Supplementary) European search report - dispatched on:EP24.06.2009
ClassificationIPC:A61K38/18
[2017/01]
CPC:
A61K38/1883 (EP,US); A61K31/122 (EP,US); A61K31/185 (EP,US);
A61K31/355 (EP,US); A61K31/375 (EP,US); A61K31/43 (EP,US);
A61K31/7088 (EP,US); A61K38/00 (EP,US); A61K38/2013 (EP,US);
A61K38/212 (EP,US); A61K38/556 (EP,US); A61K45/06 (US);
A61P25/18 (EP); A61P25/24 (EP); A61P31/00 (EP);
A61P31/04 (EP); A61P31/12 (EP); A61P31/14 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P39/06 (EP);
A61P43/00 (EP); A61P7/02 (EP); A61P7/10 (EP);
A61P9/00 (EP); A61P9/02 (EP); A61P9/04 (EP);
A61P9/06 (EP); A61P9/10 (EP); C07K14/4756 (EP,US);
A61K48/00 (EP,US); Y02A50/30 (EP,US) (-)
C-Set:
A61K31/122, A61K2300/00 (EP,US);
A61K31/185, A61K2300/00 (EP,US);
A61K31/355, A61K2300/00 (EP,US);
A61K31/375, A61K2300/00 (US,EP);
A61K31/43, A61K2300/00 (EP,US);
A61K38/2013, A61K38/00 (US,EP);
A61K38/212, A61K38/00 (US,EP);
A61K38/556, A61K38/00 (US,EP)
(-)
Former IPC [2005/29]A61K35/30, A61K38/00, A61K38/18, A61K38/46, A61K38/55, A61K48/00, C12N15/10, C07K14/475
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2017/12]
Former [2005/29]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VERFAHREN AUF NEUREGULIN-BASIS UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON KARDIOVASKULÄREN ERKRANKUNGEN[2017/01]
English:NEUREGULIN BASED METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASES[2005/29]
French:PROCEDES ET COMPOSITIONS A BASE DE NEUREGULINE POUR TRAITER LES MALADIES CARDIO-VASCULAIRES[2005/29]
Former [2005/29]VERFAHREN AUF NEUREGULIN-BASIS UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON KARDIOVASKULûREN ERKRANKUNGEN
Entry into regional phase22.12.2004National basic fee paid 
22.12.2004Search fee paid 
22.12.2004Designation fee(s) paid 
22.12.2004Examination fee paid 
Examination procedure28.11.2003Request for preliminary examination filed
International Preliminary Examining Authority: CN
22.12.2004Amendment by applicant (claims and/or description)
22.12.2004Examination requested  [2005/29]
26.11.2010Despatch of a communication from the examining division (Time limit: M06)
06.06.2011Reply to a communication from the examining division
24.06.2013Despatch of a communication from the examining division (Time limit: M06)
30.12.2013Reply to a communication from the examining division
22.05.2014Despatch of a communication from the examining division (Time limit: M06)
14.11.2014Reply to a communication from the examining division
19.10.2015Despatch of a communication from the examining division (Time limit: M02)
23.12.2015Reply to a communication from the examining division
02.08.2016Despatch of a communication from the examining division (Time limit: M04)
17.11.2016Reply to a communication from the examining division
16.12.2016Communication of intention to grant the patent
13.02.2017Fee for grant paid
13.02.2017Fee for publishing/printing paid
13.02.2017Receipt of the translation of the claim(s)
Divisional application(s)EP12194239.5  / EP2606901
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  26.11.2010
Opposition(s)02.01.2018No opposition filed within time limit [2018/09]
Fees paidRenewal fee
22.12.2004Renewal fee patent year 03
10.05.2006Renewal fee patent year 04
14.05.2007Renewal fee patent year 05
14.05.2008Renewal fee patent year 06
12.05.2009Renewal fee patent year 07
18.05.2010Renewal fee patent year 08
11.05.2011Renewal fee patent year 09
11.05.2012Renewal fee patent year 10
10.05.2013Renewal fee patent year 11
31.03.2014Renewal fee patent year 12
12.05.2015Renewal fee patent year 13
10.05.2016Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.05.2003
AT22.03.2017
CY22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
MC22.03.2017
NL22.03.2017
RO22.03.2017
SI22.03.2017
SK22.03.2017
TR22.03.2017
IE15.05.2017
LU15.05.2017
BE31.05.2017
BG22.06.2017
GR23.06.2017
PT24.07.2017
[2020/15]
Former [2019/46]HU15.05.2003
AT22.03.2017
CY22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
MC22.03.2017
NL22.03.2017
RO22.03.2017
SI22.03.2017
SK22.03.2017
IE15.05.2017
LU15.05.2017
BE31.05.2017
BG22.06.2017
GR23.06.2017
PT24.07.2017
Former [2019/31]HU15.05.2003
AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
MC22.03.2017
NL22.03.2017
RO22.03.2017
SI22.03.2017
SK22.03.2017
IE15.05.2017
LU15.05.2017
BE31.05.2017
BG22.06.2017
GR23.06.2017
PT24.07.2017
Former [2018/39]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
MC22.03.2017
NL22.03.2017
RO22.03.2017
SI22.03.2017
SK22.03.2017
IE15.05.2017
LU15.05.2017
BE31.05.2017
BG22.06.2017
GR23.06.2017
PT24.07.2017
Former [2018/23]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
MC22.03.2017
NL22.03.2017
RO22.03.2017
SI22.03.2017
SK22.03.2017
IE15.05.2017
LU15.05.2017
BG22.06.2017
GR23.06.2017
PT24.07.2017
Former [2018/17]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
MC22.03.2017
NL22.03.2017
RO22.03.2017
SI22.03.2017
SK22.03.2017
LU15.05.2017
BG22.06.2017
GR23.06.2017
PT24.07.2017
Former [2018/14]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
MC22.03.2017
NL22.03.2017
RO22.03.2017
SI22.03.2017
SK22.03.2017
LU31.05.2017
BG22.06.2017
GR23.06.2017
PT24.07.2017
Former [2018/09]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
MC22.03.2017
NL22.03.2017
RO22.03.2017
SK22.03.2017
LU31.05.2017
BG22.06.2017
GR23.06.2017
PT24.07.2017
Former [2018/06]AT22.03.2017
CZ22.03.2017
EE22.03.2017
FI22.03.2017
MC22.03.2017
NL22.03.2017
RO22.03.2017
SK22.03.2017
LU31.05.2017
BG22.06.2017
GR23.06.2017
PT24.07.2017
Former [2018/02]AT22.03.2017
CZ22.03.2017
EE22.03.2017
FI22.03.2017
NL22.03.2017
RO22.03.2017
SK22.03.2017
LU31.05.2017
BG22.06.2017
GR23.06.2017
PT24.07.2017
Former [2017/49]AT22.03.2017
CZ22.03.2017
EE22.03.2017
FI22.03.2017
NL22.03.2017
RO22.03.2017
SK22.03.2017
LU31.05.2017
BG22.06.2017
GR23.06.2017
Former [2017/48]CZ22.03.2017
FI22.03.2017
NL22.03.2017
LU31.05.2017
BG22.06.2017
GR23.06.2017
Former [2017/42]FI22.03.2017
NL22.03.2017
LU31.05.2017
BG22.06.2017
GR23.06.2017
Documents cited:Search[XY]US6136558  (BALLINGER MARCUS D [US], et al) [X] 1-9 * column 25, lines 6-8; sequence 3 * [Y] 10;
 [XY]CN1276381  (QIU LIEQUN [CN]) [X] 1-9 * page 7, paragraph 5 * [Y] 10;
 [Y]  - CRONE STEVEN A ET AL, "ErbB2 is essential in the prevention of dilated cardiomyopathy", NATURE MEDICINE, (20020501), vol. 8, no. 5, ISSN 1078-8956, pages 459 - 465, XP002531515 [Y] 10 * page 463, column L, paragraph L - column R, paragraph 1 *

DOI:   http://dx.doi.org/10.1038/nm0502-459
International search[X]WO9918976  (CAMBRIDGE NEUROSCIENCE INC [US], et al);
 [X]WO0037095  (VICTOR CHANG CARDIAC RESEARCH [AU], et al);
 [X]WO0064400  (CAMBRIDGE NEUROSCIENCE INC [US], et al);
 [X]WO0164877  (DECODE GENETICS EHF [IS], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.